Cargando…
Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting neuroendocrine tumors of the adrenal medulla and sympathetic/parasympathetic ganglion cells, respectively. Excessive release of catecholamines leads to episodic symptoms and signs of PPGL, which include hypertension, heada...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678461/ https://www.ncbi.nlm.nih.gov/pubmed/31277296 http://dx.doi.org/10.3390/cancers11070936 |
_version_ | 1783441106433736704 |
---|---|
author | Mamilla, Divya Araque, Katherine A. Brofferio, Alessandra Gonzales, Melissa K. Sullivan, James N. Nilubol, Naris Pacak, Karel |
author_facet | Mamilla, Divya Araque, Katherine A. Brofferio, Alessandra Gonzales, Melissa K. Sullivan, James N. Nilubol, Naris Pacak, Karel |
author_sort | Mamilla, Divya |
collection | PubMed |
description | Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting neuroendocrine tumors of the adrenal medulla and sympathetic/parasympathetic ganglion cells, respectively. Excessive release of catecholamines leads to episodic symptoms and signs of PPGL, which include hypertension, headache, palpitations, and diaphoresis. Intraoperatively, large amounts of catecholamines are released into the bloodstream through handling and manipulation of the tumor(s). In contrast, there could also be an abrupt decline in catecholamine levels after tumor resection. Because of such binary manifestations of PPGL, patients may develop perplexing and substantially devastating cardiovascular complications during the perioperative period. These complications include hypertension, hypotension, arrhythmias, myocardial infarction, heart failure, and cerebrovascular accident. Other complications seen in the postoperative period include fever, hypoglycemia, cortisol deficiency, urinary retention, etc. In the interest of safe patient care, such emergencies require precise diagnosis and treatment. Surgeons, anesthesiologists, and intensivists must be aware of the clinical manifestations and complications associated with a sudden increase or decrease in catecholamine levels and should work closely together to be able to provide appropriate management to minimize morbidity and mortality associated with PPGLs. |
format | Online Article Text |
id | pubmed-6678461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66784612019-08-19 Postoperative Management in Patients with Pheochromocytoma and Paraganglioma Mamilla, Divya Araque, Katherine A. Brofferio, Alessandra Gonzales, Melissa K. Sullivan, James N. Nilubol, Naris Pacak, Karel Cancers (Basel) Review Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting neuroendocrine tumors of the adrenal medulla and sympathetic/parasympathetic ganglion cells, respectively. Excessive release of catecholamines leads to episodic symptoms and signs of PPGL, which include hypertension, headache, palpitations, and diaphoresis. Intraoperatively, large amounts of catecholamines are released into the bloodstream through handling and manipulation of the tumor(s). In contrast, there could also be an abrupt decline in catecholamine levels after tumor resection. Because of such binary manifestations of PPGL, patients may develop perplexing and substantially devastating cardiovascular complications during the perioperative period. These complications include hypertension, hypotension, arrhythmias, myocardial infarction, heart failure, and cerebrovascular accident. Other complications seen in the postoperative period include fever, hypoglycemia, cortisol deficiency, urinary retention, etc. In the interest of safe patient care, such emergencies require precise diagnosis and treatment. Surgeons, anesthesiologists, and intensivists must be aware of the clinical manifestations and complications associated with a sudden increase or decrease in catecholamine levels and should work closely together to be able to provide appropriate management to minimize morbidity and mortality associated with PPGLs. MDPI 2019-07-03 /pmc/articles/PMC6678461/ /pubmed/31277296 http://dx.doi.org/10.3390/cancers11070936 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mamilla, Divya Araque, Katherine A. Brofferio, Alessandra Gonzales, Melissa K. Sullivan, James N. Nilubol, Naris Pacak, Karel Postoperative Management in Patients with Pheochromocytoma and Paraganglioma |
title | Postoperative Management in Patients with Pheochromocytoma and Paraganglioma |
title_full | Postoperative Management in Patients with Pheochromocytoma and Paraganglioma |
title_fullStr | Postoperative Management in Patients with Pheochromocytoma and Paraganglioma |
title_full_unstemmed | Postoperative Management in Patients with Pheochromocytoma and Paraganglioma |
title_short | Postoperative Management in Patients with Pheochromocytoma and Paraganglioma |
title_sort | postoperative management in patients with pheochromocytoma and paraganglioma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678461/ https://www.ncbi.nlm.nih.gov/pubmed/31277296 http://dx.doi.org/10.3390/cancers11070936 |
work_keys_str_mv | AT mamilladivya postoperativemanagementinpatientswithpheochromocytomaandparaganglioma AT araquekatherinea postoperativemanagementinpatientswithpheochromocytomaandparaganglioma AT brofferioalessandra postoperativemanagementinpatientswithpheochromocytomaandparaganglioma AT gonzalesmelissak postoperativemanagementinpatientswithpheochromocytomaandparaganglioma AT sullivanjamesn postoperativemanagementinpatientswithpheochromocytomaandparaganglioma AT nilubolnaris postoperativemanagementinpatientswithpheochromocytomaandparaganglioma AT pacakkarel postoperativemanagementinpatientswithpheochromocytomaandparaganglioma |